以膈肌做功为目标滴定吸气支持实现肺与膈肌保护性通气:一项随机临床试验
本研究为在荷兰一家三级学术医院内外科混合ICU开展的概念验证性随机临床试验,纳入40例以部分支持模式通气的呼吸衰竭患者。干预组每小时滴定吸气支持,使跨膈压摆动处于预设「膈肌保护」范围(3-12 cm H2O),对照组接受标准治疗;两组连续监测跨膈压、跨肺压和潮气量24小时。干预组处于「膈肌保护」范围的呼吸比例中位数为81%(四分位距64-86%),对照组为35%(16-60%),p<0.001;两组动态跨肺压(20.5±7.1 vs 18.5±7.0 cm H2O,p=0.321)与潮气量(7.56±1.47 vs 7.54±1.22 mL/kg,p=0.961)无差异。作者认为,该结果为后续以患者为中心的结局指标开展进一步研究提供了有力依据。
要点
- 干预组每小时按跨膈压摆动滴定吸气支持,使处于「膈肌保护」范围(3-12 cm H2O)的呼吸比例中位数达81%(四分位距64-86%),对照组为35%(16-60%),p<0.001。
- 两组动态跨肺压无差异:干预组20.5±7.1 vs 对照组18.5±7.0 cm H2O,p=0.321。
- 两组潮气量无差异:干预组7.56±1.47 vs 对照组7.54±1.22 mL/kg,p=0.961。
- 该研究为概念验证性随机临床试验,样本量40例,作者认为结果为后续以患者为中心的结局指标开展进一步研究提供了有力依据。
适用人群与场景
- 荷兰一家三级学术医院内外科混合ICU中,以部分支持模式通气的呼吸衰竭患者(n=40)。
诊断标准与关键阈值
- 预设「膈肌保护」范围为跨膈压摆动3-12 cm H2O。
处置流程与药物剂量
- 干预组每小时滴定吸气支持,使跨膈压摆动处于3-12 cm H2O的「膈肌保护」范围;对照组接受标准治疗。
- 两组均连续监测跨膈压、跨肺压和潮气量24小时。
研究设计与关键结果
- 研究类型:随机临床试验;样本量n=40;单中心(荷兰一家三级学术医院内外科混合ICU);人群为以部分支持模式通气的呼吸衰竭患者。
- 干预与对照:干预组每小时按跨膈压摆动滴定吸气支持至3-12 cm H2O「膈肌保护」范围,对照组接受标准治疗。
- 主要终点:干预组处于「膈肌保护」范围的呼吸比例中位数81%(四分位距64-86%),对照组35%(16-60%),p<0.001。
- 动态跨肺压:干预组20.5±7.1 vs 对照组18.5±7.0 cm H2O,p=0.321,无差异。
- 潮气量:干预组7.56±1.47 vs 对照组7.54±1.22 mL/kg,p=0.961,无差异。
证据类型、等级与局限
- 证据类型:随机临床试验(概念验证性研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该研究为以患者为中心的结局指标开展进一步研究提供了有力依据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Lung- and diaphragm-protective ventilation is a novel concept that aims to limit the detrimental effects of mechanical ventilation on the diaphragm while remaining within limits of lung-protective ventilation. The premise is that low breathing effort under mechanical ventilation causes diaphragm atrophy, whereas excessive breathing effort induces diaphragm and lung injury. In a proof-of-concept study, we aimed to assess whether titration of inspiratory support based on diaphragm effort increases the time that patients have effort in a predefined "diaphragm-protective" range, without compromising lung-protective ventilation.
DESIGN: Randomized clinical trial.
SETTING: Mixed medical-surgical ICU in a tertiary academic hospital in the Netherlands.
PATIENTS: Patients (n = 40) with respiratory failure ventilated in a partially-supported mode.
INTERVENTIONS: In the intervention group, inspiratory support was titrated hourly to obtain transdiaphragmatic pressure swings in the predefined "diaphragm-protective" range (3-12 cm H2O). The control group received standard-of-care.
MEASUREMENTS AND MAIN RESULTS: Transdiaphragmatic pressure, transpulmonary pressure, and tidal volume were monitored continuously for 24 hours in both groups. In the intervention group, more breaths were within "diaphragm-protective" range compared with the control group (median 81%; interquartile range [64-86%] vs 35% [16-60%], respectively; p < 0.001). Dynamic transpulmonary pressures (20.5 ± 7.1 vs 18.5 ± 7.0 cm H2O; p = 0.321) and tidal volumes (7.56 ± 1.47 vs 7.54 ± 1.22 mL/kg; p = 0.961) were not different in the intervention and control group, respectively.
CONCLUSIONS: Titration of inspiratory support based on patient breathing effort greatly increased the time that patients had diaphragm effort in the predefined "diaphragm-protective" range without compromising tidal volumes and transpulmonary pressures. This study provides a strong rationale for further studies powered on patient-centered outcomes.
参考来源
- de Vries HJ, Jonkman AH, de Grooth HJ, et al. Lung- and Diaphragm-Protective Ventilation by Titrating Inspiratory Support to Diaphragm Effort: A Randomized Clinical Trial. Crit Care Med. 2022. PMID: 35100192. doi:10.1097/CCM.0000000000005395
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。